Fred E Cooperrider
Examiner (ID: 11124)
Most Active Art Unit | 2723 |
Art Unit(s) | 2723, 2623 |
Total Applications | 39 |
Issued Applications | 33 |
Pending Applications | 2 |
Abandoned Applications | 4 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11647826
[patent_doc_number] => 20170143726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS TO MODULATE T CELL RESPONSES'
[patent_app_type] => utility
[patent_app_number] => 15/420892
[patent_app_country] => US
[patent_app_date] => 2017-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 30748
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15420892
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/420892 | ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS TO MODULATE T CELL RESPONSES | Jan 30, 2017 | Abandoned |
Array
(
[id] => 16970475
[patent_doc_number] => 11066436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => 5'-phosphorothiolate mRNA 5'-end (cap) analogs, mRNA comprising the same, method of obtaining and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/073499
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 14752
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073499
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073499 | 5'-phosphorothiolate mRNA 5'-end (cap) analogs, mRNA comprising the same, method of obtaining and uses thereof | Jan 26, 2017 | Issued |
Array
(
[id] => 13690063
[patent_doc_number] => 20170355986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 15/409501
[patent_app_country] => US
[patent_app_date] => 2017-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15409501
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/409501 | ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION | Jan 17, 2017 | Abandoned |
Array
(
[id] => 16213898
[patent_doc_number] => 10729690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-04
[patent_title] => Antihelminthic medications for pathogenic nematodes
[patent_app_type] => utility
[patent_app_number] => 16/069399
[patent_app_country] => US
[patent_app_date] => 2017-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 27
[patent_no_of_words] => 17800
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069399
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/069399 | Antihelminthic medications for pathogenic nematodes | Jan 11, 2017 | Issued |
Array
(
[id] => 11809863
[patent_doc_number] => 09714425
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-25
[patent_title] => 'Double stranded RNA constructs for aphid control'
[patent_app_type] => utility
[patent_app_number] => 15/402317
[patent_app_country] => US
[patent_app_date] => 2017-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5443
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15402317
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/402317 | Double stranded RNA constructs for aphid control | Jan 9, 2017 | Issued |
Array
(
[id] => 13622873
[patent_doc_number] => 20180362988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => METHODS FOR REDUCING LRRK2 EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 16/063903
[patent_app_country] => US
[patent_app_date] => 2017-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063903
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/063903 | Methods for reducing LRRK2 expression | Jan 4, 2017 | Issued |
Array
(
[id] => 15405271
[patent_doc_number] => 20200022957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => KINASE AND UBIQUITIN LIGASE INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/060266
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060266
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060266 | KINASE AND UBIQUITIN LIGASE INHIBITORS AND USES THEREOF | Dec 15, 2016 | Abandoned |
Array
(
[id] => 13604151
[patent_doc_number] => 20180353624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => ADENO-ASSOCIATED VIRAL VECTORS USEFUL IN TREATMENT OF SPINAL MUSCULAR ATROPY
[patent_app_type] => utility
[patent_app_number] => 16/061109
[patent_app_country] => US
[patent_app_date] => 2016-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061109
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/061109 | ADENO-ASSOCIATED VIRAL VECTORS USEFUL IN TREATMENT OF SPINAL MUSCULAR ATROPY | Dec 13, 2016 | Abandoned |
Array
(
[id] => 13778691
[patent_doc_number] => 20190002884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => METHODS OF TREATING CANCER BY INHIBITION OF DNA REPAIR PROTEINS USING ANTISENSE BASED THERAPIES
[patent_app_type] => utility
[patent_app_number] => 16/065641
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16065641
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/065641 | Methods of treating cancer by inhibition of DNA repair proteins using antisense based therapies | Dec 12, 2016 | Issued |
Array
(
[id] => 13604139
[patent_doc_number] => 20180353618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => Heterologous UTR Sequences for Enhanced mRNA Expression
[patent_app_type] => utility
[patent_app_number] => 15/781827
[patent_app_country] => US
[patent_app_date] => 2016-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15781827
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/781827 | Heterologous UTR sequences for enhanced mRNA expression | Dec 8, 2016 | Issued |
Array
(
[id] => 11512938
[patent_doc_number] => 20170080012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'DEFIBROTIDE FOR USE IN PROPHYLAXIS AND/OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD)'
[patent_app_type] => utility
[patent_app_number] => 15/366213
[patent_app_country] => US
[patent_app_date] => 2016-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4909
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15366213
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/366213 | Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (GVHD) | Nov 30, 2016 | Issued |
Array
(
[id] => 15604261
[patent_doc_number] => 10583171
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => NMDAR antagonists for the treatment of diseases associated with angiogenesis
[patent_app_type] => utility
[patent_app_number] => 15/779369
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 12031
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779369
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/779369 | NMDAR antagonists for the treatment of diseases associated with angiogenesis | Nov 29, 2016 | Issued |
Array
(
[id] => 11649518
[patent_doc_number] => 20170145419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/365479
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 99
[patent_figures_cnt] => 99
[patent_no_of_words] => 45052
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15365479
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/365479 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | Nov 29, 2016 | Abandoned |
Array
(
[id] => 13079871
[patent_doc_number] => 10059994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome
[patent_app_type] => utility
[patent_app_number] => 15/356745
[patent_app_country] => US
[patent_app_date] => 2016-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 9349
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15356745
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/356745 | Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome | Nov 20, 2016 | Issued |
Array
(
[id] => 15483607
[patent_doc_number] => 10557137
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-11
[patent_title] => Modulating apolipoprotein (a) expression
[patent_app_type] => utility
[patent_app_number] => 15/772649
[patent_app_country] => US
[patent_app_date] => 2016-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 21151
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15772649
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/772649 | Modulating apolipoprotein (a) expression | Nov 6, 2016 | Issued |
Array
(
[id] => 12166283
[patent_doc_number] => 09885047
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-06
[patent_title] => 'Modulation of TMPRSS6 expression'
[patent_app_type] => utility
[patent_app_number] => 15/343104
[patent_app_country] => US
[patent_app_date] => 2016-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23750
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15343104
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/343104 | Modulation of TMPRSS6 expression | Nov 2, 2016 | Issued |
Array
(
[id] => 13428661
[patent_doc_number] => 20180265873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => Genetic Or Pharmacological Reduction Of Perk Enhances Cortical- And Hippocampus-Dependent Cognitive Function
[patent_app_type] => utility
[patent_app_number] => 15/335466
[patent_app_country] => US
[patent_app_date] => 2016-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15335466
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/335466 | Genetic or pharmacological reduction of PERK enhances cortical- and hippocampus-dependent cognitive function | Oct 26, 2016 | Issued |
Array
(
[id] => 12490704
[patent_doc_number] => 09994848
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Pharmaceutical composition for preventing and teating endocrine disrupting chemicals-induced diseases and treating method using the same
[patent_app_type] => utility
[patent_app_number] => 15/336009
[patent_app_country] => US
[patent_app_date] => 2016-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 4765
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15336009
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/336009 | Pharmaceutical composition for preventing and teating endocrine disrupting chemicals-induced diseases and treating method using the same | Oct 26, 2016 | Issued |
Array
(
[id] => 14978295
[patent_doc_number] => 10443053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-15
[patent_title] => Diagnosis and treatment of Friedreich's ataxia
[patent_app_type] => utility
[patent_app_number] => 15/332692
[patent_app_country] => US
[patent_app_date] => 2016-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 21
[patent_no_of_words] => 10692
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15332692
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/332692 | Diagnosis and treatment of Friedreich's ataxia | Oct 23, 2016 | Issued |
Array
(
[id] => 16013537
[patent_doc_number] => 20200181611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => NUCLEIC ACIDS COMPRISING IMPREFECT HAIRPINS
[patent_app_type] => utility
[patent_app_number] => 16/342302
[patent_app_country] => US
[patent_app_date] => 2016-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16342302
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/342302 | NUCLEIC ACIDS COMPRISING IMPREFECT HAIRPINS | Oct 18, 2016 | Abandoned |